TABLE 1. Sample characteristics of respondents and non-respondents.
| Respondents n=599 |
Non-respondents n=1600 |
|
|---|---|---|
| Variables | Freq (%) | Freq (%) |
| Gender*** | ||
| Female | 316 (52.8) | 612 (39.8) |
| Male | 282 (47.2) | 927 (60.2) |
| Race/ethnicity | ||
| White | 380 (64.7) | NA |
| Black | 24 (4.1) | |
| API | 36 (6.1) | |
| Hispanic/Latino | 138 (23.5) | |
| AmerInd | 7 (1.2) | |
| Employment status | ||
| Unemployed1 | 73 (12.5) | NA |
| Employed/Occupied2 | 510 (87.5) | |
| Education | ||
| HS Grad or less | 115 (19.7) | NA |
| Some college | 270 (46.2) | |
| 4-year college grad | 199 (34.1) | |
| Marital status | ||
| No | 318 (54.0) | NA |
| Yes | 271 (46.0) | |
| Income | ||
| ≤$25K | 201 (35.3) | NA |
| $25-$75K | 234 (41.1) | |
| >$75K | 135 (23.7) | |
| Cancer Type*** | ||
| Leukemia | 225 (37.7) | 173 (21.1) |
| Hodgkins' disease | 98 (16.4) | 121 (14.8) |
| Non-Hodgkin's Lymphoma | 54 (9.0) | 74 (9.0) |
| CNS/Brain Tumor | 79 (13.2) | 191 (23.3) |
| Solid tumors/soft tissue tumors | 73 (12.2) | 74 (9.0) |
| Kidney (e.g., Wilm's) | 25 (4.2) | 34 (4.2) |
| Other3 | 43 (7.2) | 152 (18.6) |
| Reports current health problems(other than cancer related) | ||
| No | 267 (45.7) | NA |
| Yes | 317 (54.3) | |
| Age at study, in years | ||
| Mean (SD) | 27.0 (5.5) | 26.5 (5.5) |
| Range | ||
| Age at diagnosis, in years | ||
| Mean (SD) | 11.0 (6.0) | 10.8 (6.1) |
| Range | ||
| Years since diagnosis | ||
| Mean (SD) | 16.0 (7.0) | 15.7 (6.9) |
| Range | ||
*
Indicates statistically significant differences at p<0.05;
**
Indicates statistically significant differences at p<0.01;
***
Indicates statistically significant differences at p<0.001
NA=not available from participating institutions; Frequencies do not always add up to 599 for survivors or 1600 for non-respondents due to missing data.
1
includes those “on leave/disability,” “unemployed,” or “permanently unable to work.”
2
includes “full-time employment,” “part-time employment,” “student,” or “homemaker.”
3
Includes: germ cell tumors, retinoblastoma, neuroblastoma, and other tumors not specified